[go: up one dir, main page]

IL117531A - Transparent rapid release compositions of non-steroidal analgesics - Google Patents

Transparent rapid release compositions of non-steroidal analgesics

Info

Publication number
IL117531A
IL117531A IL11753196A IL11753196A IL117531A IL 117531 A IL117531 A IL 117531A IL 11753196 A IL11753196 A IL 11753196A IL 11753196 A IL11753196 A IL 11753196A IL 117531 A IL117531 A IL 117531A
Authority
IL
Israel
Prior art keywords
pct
rapid release
release compositions
steroidal analgesics
date sep
Prior art date
Application number
IL11753196A
Other languages
English (en)
Other versions
IL117531A0 (en
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL117531A0 publication Critical patent/IL117531A0/xx
Publication of IL117531A publication Critical patent/IL117531A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Finger-Pressure Massage (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL11753196A 1995-03-21 1996-03-18 Transparent rapid release compositions of non-steroidal analgesics IL117531A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19509805A DE19509805A1 (de) 1995-03-21 1995-03-21 Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica

Publications (2)

Publication Number Publication Date
IL117531A0 IL117531A0 (en) 1996-07-23
IL117531A true IL117531A (en) 2000-01-31

Family

ID=7757016

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11753196A IL117531A (en) 1995-03-21 1996-03-18 Transparent rapid release compositions of non-steroidal analgesics

Country Status (21)

Country Link
US (1) US6063821A (xx)
EP (1) EP0817612B1 (xx)
JP (1) JPH11502209A (xx)
KR (1) KR19980703160A (xx)
AT (1) ATE196078T1 (xx)
AU (1) AU5105396A (xx)
BR (1) BR9607867A (xx)
CA (1) CA2213719C (xx)
CZ (1) CZ286011B6 (xx)
DE (2) DE19509805A1 (xx)
DK (1) DK0817612T3 (xx)
EA (1) EA000434B1 (xx)
ES (1) ES2151150T3 (xx)
GR (1) GR3034441T3 (xx)
HU (1) HU221614B (xx)
IL (1) IL117531A (xx)
NO (1) NO318236B1 (xx)
PT (1) PT817612E (xx)
TW (1) TW416850B (xx)
WO (1) WO1996029053A1 (xx)
ZA (1) ZA962241B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602206A1 (de) 1996-01-23 1997-07-24 Basf Ag Zubereitungen nichtsteroidaler Analgetika
DE59711923D1 (de) 1996-11-15 2004-10-21 Merck Patent Gmbh Verfahren zur herstellung von geformten oder ungeformten polyolmassen und hergestelle zusammensetzungen
EP1001748B1 (en) * 1997-07-25 2006-04-19 Alpex Pharma S.A. A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE60028754T2 (de) * 1999-11-12 2007-05-31 Abbott Laboratories, Abbott Park Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
ES2170645B1 (es) * 2000-03-23 2003-10-01 Alcala Farma S L Lab Forma farmaceutica solida de administracion oral de una sal de metamizol soluble en agua, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
AU2003249474A1 (en) 2002-08-12 2004-02-25 Pfizer Products Inc. Pharmaceutical compositions of semi-ordered drugs and polymers
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
GB0403098D0 (en) 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
AR048033A1 (es) * 2004-03-12 2006-03-22 Smithkline Beecham Plc Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
US20070043096A1 (en) * 2005-07-18 2007-02-22 Horizon Therapeutics, Inc. Unit dose form with ibuprofen-famotidine admixture
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
EP2219624A2 (en) 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
CA2727630A1 (en) * 2008-06-13 2009-12-17 Glaxo Group Limited Pharmaceutical formulations
JP5499703B2 (ja) * 2009-12-28 2014-05-21 ライオン株式会社 イブプロフェン含有製剤
CN103153580A (zh) * 2010-03-26 2013-06-12 陶氏环球技术有限责任公司 制备熔体挤出的膜的方法和熔体挤出的膜
JP2013523634A (ja) * 2010-03-26 2013-06-17 ダウ グローバル テクノロジーズ エルエルシー 溶融押出フィルム

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3830355A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur herstellung von pharmazeutischen tabletten
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel
GB9302259D0 (en) * 1993-02-05 1993-03-24 Cerestar Holding Bv Starch based material
DE19509807A1 (de) * 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren

Also Published As

Publication number Publication date
EP0817612A1 (de) 1998-01-14
ES2151150T3 (es) 2000-12-16
NO974338L (no) 1997-09-19
EP0817612B1 (de) 2000-09-06
EA199700247A1 (ru) 1998-02-26
ZA962241B (en) 1997-09-22
ATE196078T1 (de) 2000-09-15
TW416850B (en) 2001-01-01
BR9607867A (pt) 1998-06-30
CZ286011B6 (cs) 1999-12-15
US6063821A (en) 2000-05-16
PT817612E (pt) 2001-03-30
MX9706652A (es) 1997-11-29
NO974338D0 (no) 1997-09-19
DE59605848D1 (de) 2000-10-12
DE19509805A1 (de) 1996-09-26
GR3034441T3 (en) 2000-12-29
CZ280297A3 (cs) 1998-03-18
KR19980703160A (ko) 1998-10-15
HU221614B (hu) 2002-11-28
HUP9801152A2 (hu) 1998-08-28
WO1996029053A1 (de) 1996-09-26
DK0817612T3 (da) 2000-11-20
CA2213719C (en) 2005-01-11
IL117531A0 (en) 1996-07-23
NO318236B1 (no) 2005-02-21
EA000434B1 (ru) 1999-08-26
HUP9801152A3 (en) 2000-06-28
CA2213719A1 (en) 1996-09-26
JPH11502209A (ja) 1999-02-23
AU5105396A (en) 1996-10-08

Similar Documents

Publication Publication Date Title
IL117531A0 (en) Transparent rapid release compositions of non-steroidal analgesics
NO974337D0 (no) Lagringsstabile legemiddelformer
ATE218353T1 (de) Antimikrobielles mittel bestehend aus gläser mit kontrollierter abgabe
AU2916792A (en) Multilayer controlled release tablets containing both naproxen and naproxen sodium salt
NO964939L (no) Fremgangsmåte for fremstilling av virkestoffpreparater i form av en fast lösning av virkestoffet i en polymermatriks, samt virkestoffpreparater fremstilt ved hjelp av denne fremgangsmåte
EP0753296A3 (en) Oral formulations containing S (+) - ibuprofen
ATE168886T1 (de) Abgabevorrichtung mit eingekapselten hilfsmitteln
DK0710108T3 (da) Flydende, farmaceutisk præparat til oral anvendelse indeholdende 2-(4-isobutylphenyl)-propionsyre
DE69621785D1 (de) Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten
AU2135695A (en) Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
AU2736495A (en) Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites
PL316079A1 (en) Antiussive composition containing an antitussive agent and benzidamine
DK0749304T4 (da) Retardtablet med et indhold af diclofenac-Na
PT833626E (pt) Antraquinonas mono- e di-sulfo- substituidas e a sua utilizacao para o tratamento de disturbios da matriz do osso
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c
PL335652A1 (en) Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acid
YU71595A (sh) Optičko pomoćno sredstvo

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed